BriaCell’s Clinical Data Accepted to be Presented at the Annual Symposium of Society of Surgical Oncology 2020 in Boston

    NEXT STORY
    Sharps Compliance Reports Fiscal 2020 Second Quarter Results
    PREV STORY
    Snow Companies Launches New Tool for Finding Branded Social Media Pages
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Sorrento Therapeutics Chairman/CEO update to stockholders

    SAN DIEGO, March 28, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE) Dear Sorrento ...

    author_avatar
    NASDAQ Market News

    CRISPR Therapeutics Reports Financial Results for the Three Months Ended March 31, 2017 and Provides Business Update

    On track to file for clinical trial authorization (CTA) for lead program in beta-thalassemia ...

    author_avatar
    NASDAQ Market News

    Paratek Pharmaceuticals Reports First Quarter 2018 Financial Results

    -- New drug applications for omadacycline accepted for priority review by FDA; PDUFA action ...

    author_avatar
    NASDAQ Market News